ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global In Vivo and In Vitro ADME Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-8G8957
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global In Vivo and In Vitro ADME Market Insights Forecast to 2028
BUY CHAPTERS

Global In Vivo and In Vitro ADME Market Research Report 2025

Code: QYRE-Auto-8G8957
Report
September 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Charles River
LabCorp
ICON
Syneos Health
Envigo
Curia
Evotec AG
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences

In Vivo and In Vitro ADME Market

The global market for In Vivo and In Vitro ADME was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
In the early stages of drug discovery, it is important to understand the key physicochemical properties and structural motifs that drive the efficacy and safety profile of a compound candidate. In vitro and in vivo ADME is used to identify the attributes of absorption, distribution, metabolism, and excretion. ADME assays are critical in gaining insight into metabolism and potential drug interactions.
North American market for In Vivo and In Vitro ADME is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for In Vivo and In Vitro ADME is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for In Vivo and In Vitro ADME in Biopharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of In Vivo and In Vitro ADME include Charles River, Labcorp, ICON, Syneos Health, Envigo, Curia, Evotec, Bioduro-Sundia, Lonza, WuXi AppTec, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for In Vivo and In Vitro ADME, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vivo and In Vitro ADME.
The In Vivo and In Vitro ADME market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In Vivo and In Vitro ADME market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vivo and In Vitro ADME companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of In Vivo and In Vitro ADME Market Report

Report Metric Details
Report Name In Vivo and In Vitro ADME Market
Segment by Type
  • Small Molecules
  • Biologics
Segment by Application
  • Biopharmaceutical Companies
  • Government and Academic Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River, Labcorp, ICON, Syneos Health, Envigo, Curia, Evotec, Bioduro-Sundia, Lonza, WuXi AppTec, IQVIA, Tecan Group, Pharmaron, Shanghai Medicilon, ChemPartner, Joinn Laboratories, RTI International, Eurofins Scientific, Aragen Life Sciences, Sai Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of In Vivo and In Vitro ADME company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the In Vivo and In Vitro ADME Market report?

Ans: The main players in the In Vivo and In Vitro ADME Market are Charles River, Labcorp, ICON, Syneos Health, Envigo, Curia, Evotec, Bioduro-Sundia, Lonza, WuXi AppTec, IQVIA, Tecan Group, Pharmaron, Shanghai Medicilon, ChemPartner, Joinn Laboratories, RTI International, Eurofins Scientific, Aragen Life Sciences, Sai Life Sciences

What are the Application segmentation covered in the In Vivo and In Vitro ADME Market report?

Ans: The Applications covered in the In Vivo and In Vitro ADME Market report are Biopharmaceutical Companies, Government and Academic Institutes, Others

What are the Type segmentation covered in the In Vivo and In Vitro ADME Market report?

Ans: The Types covered in the In Vivo and In Vitro ADME Market report are Small Molecules, Biologics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vivo and In Vitro ADME Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global In Vivo and In Vitro ADME Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vivo and In Vitro ADME Market Perspective (2020-2031)
2.2 Global In Vivo and In Vitro ADME Growth Trends by Region
2.2.1 Global In Vivo and In Vitro ADME Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In Vivo and In Vitro ADME Historic Market Size by Region (2020-2025)
2.2.3 In Vivo and In Vitro ADME Forecasted Market Size by Region (2026-2031)
2.3 In Vivo and In Vitro ADME Market Dynamics
2.3.1 In Vivo and In Vitro ADME Industry Trends
2.3.2 In Vivo and In Vitro ADME Market Drivers
2.3.3 In Vivo and In Vitro ADME Market Challenges
2.3.4 In Vivo and In Vitro ADME Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vivo and In Vitro ADME Players by Revenue
3.1.1 Global Top In Vivo and In Vitro ADME Players by Revenue (2020-2025)
3.1.2 Global In Vivo and In Vitro ADME Revenue Market Share by Players (2020-2025)
3.2 Global In Vivo and In Vitro ADME Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In Vivo and In Vitro ADME Revenue
3.4 Global In Vivo and In Vitro ADME Market Concentration Ratio
3.4.1 Global In Vivo and In Vitro ADME Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vivo and In Vitro ADME Revenue in 2024
3.5 Global Key Players of In Vivo and In Vitro ADME Head office and Area Served
3.6 Global Key Players of In Vivo and In Vitro ADME, Product and Application
3.7 Global Key Players of In Vivo and In Vitro ADME, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vivo and In Vitro ADME Breakdown Data by Type
4.1 Global In Vivo and In Vitro ADME Historic Market Size by Type (2020-2025)
4.2 Global In Vivo and In Vitro ADME Forecasted Market Size by Type (2026-2031)
5 In Vivo and In Vitro ADME Breakdown Data by Application
5.1 Global In Vivo and In Vitro ADME Historic Market Size by Application (2020-2025)
5.2 Global In Vivo and In Vitro ADME Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In Vivo and In Vitro ADME Market Size (2020-2031)
6.2 North America In Vivo and In Vitro ADME Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In Vivo and In Vitro ADME Market Size by Country (2020-2025)
6.4 North America In Vivo and In Vitro ADME Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vivo and In Vitro ADME Market Size (2020-2031)
7.2 Europe In Vivo and In Vitro ADME Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In Vivo and In Vitro ADME Market Size by Country (2020-2025)
7.4 Europe In Vivo and In Vitro ADME Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vivo and In Vitro ADME Market Size (2020-2031)
8.2 Asia-Pacific In Vivo and In Vitro ADME Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In Vivo and In Vitro ADME Market Size by Region (2020-2025)
8.4 Asia-Pacific In Vivo and In Vitro ADME Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vivo and In Vitro ADME Market Size (2020-2031)
9.2 Latin America In Vivo and In Vitro ADME Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In Vivo and In Vitro ADME Market Size by Country (2020-2025)
9.4 Latin America In Vivo and In Vitro ADME Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vivo and In Vitro ADME Market Size (2020-2031)
10.2 Middle East & Africa In Vivo and In Vitro ADME Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In Vivo and In Vitro ADME Market Size by Country (2020-2025)
10.4 Middle East & Africa In Vivo and In Vitro ADME Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River In Vivo and In Vitro ADME Introduction
11.1.4 Charles River Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Details
11.2.2 Labcorp Business Overview
11.2.3 Labcorp In Vivo and In Vitro ADME Introduction
11.2.4 Labcorp Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.2.5 Labcorp Recent Development
11.3 ICON
11.3.1 ICON Company Details
11.3.2 ICON Business Overview
11.3.3 ICON In Vivo and In Vitro ADME Introduction
11.3.4 ICON Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.3.5 ICON Recent Development
11.4 Syneos Health
11.4.1 Syneos Health Company Details
11.4.2 Syneos Health Business Overview
11.4.3 Syneos Health In Vivo and In Vitro ADME Introduction
11.4.4 Syneos Health Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.4.5 Syneos Health Recent Development
11.5 Envigo
11.5.1 Envigo Company Details
11.5.2 Envigo Business Overview
11.5.3 Envigo In Vivo and In Vitro ADME Introduction
11.5.4 Envigo Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.5.5 Envigo Recent Development
11.6 Curia
11.6.1 Curia Company Details
11.6.2 Curia Business Overview
11.6.3 Curia In Vivo and In Vitro ADME Introduction
11.6.4 Curia Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.6.5 Curia Recent Development
11.7 Evotec
11.7.1 Evotec Company Details
11.7.2 Evotec Business Overview
11.7.3 Evotec In Vivo and In Vitro ADME Introduction
11.7.4 Evotec Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.7.5 Evotec Recent Development
11.8 Bioduro-Sundia
11.8.1 Bioduro-Sundia Company Details
11.8.2 Bioduro-Sundia Business Overview
11.8.3 Bioduro-Sundia In Vivo and In Vitro ADME Introduction
11.8.4 Bioduro-Sundia Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.8.5 Bioduro-Sundia Recent Development
11.9 Lonza
11.9.1 Lonza Company Details
11.9.2 Lonza Business Overview
11.9.3 Lonza In Vivo and In Vitro ADME Introduction
11.9.4 Lonza Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.9.5 Lonza Recent Development
11.10 WuXi AppTec
11.10.1 WuXi AppTec Company Details
11.10.2 WuXi AppTec Business Overview
11.10.3 WuXi AppTec In Vivo and In Vitro ADME Introduction
11.10.4 WuXi AppTec Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.10.5 WuXi AppTec Recent Development
11.11 IQVIA
11.11.1 IQVIA Company Details
11.11.2 IQVIA Business Overview
11.11.3 IQVIA In Vivo and In Vitro ADME Introduction
11.11.4 IQVIA Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.11.5 IQVIA Recent Development
11.12 Tecan Group
11.12.1 Tecan Group Company Details
11.12.2 Tecan Group Business Overview
11.12.3 Tecan Group In Vivo and In Vitro ADME Introduction
11.12.4 Tecan Group Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.12.5 Tecan Group Recent Development
11.13 Pharmaron
11.13.1 Pharmaron Company Details
11.13.2 Pharmaron Business Overview
11.13.3 Pharmaron In Vivo and In Vitro ADME Introduction
11.13.4 Pharmaron Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.13.5 Pharmaron Recent Development
11.14 Shanghai Medicilon
11.14.1 Shanghai Medicilon Company Details
11.14.2 Shanghai Medicilon Business Overview
11.14.3 Shanghai Medicilon In Vivo and In Vitro ADME Introduction
11.14.4 Shanghai Medicilon Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.14.5 Shanghai Medicilon Recent Development
11.15 ChemPartner
11.15.1 ChemPartner Company Details
11.15.2 ChemPartner Business Overview
11.15.3 ChemPartner In Vivo and In Vitro ADME Introduction
11.15.4 ChemPartner Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.15.5 ChemPartner Recent Development
11.16 Joinn Laboratories
11.16.1 Joinn Laboratories Company Details
11.16.2 Joinn Laboratories Business Overview
11.16.3 Joinn Laboratories In Vivo and In Vitro ADME Introduction
11.16.4 Joinn Laboratories Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.16.5 Joinn Laboratories Recent Development
11.17 RTI International
11.17.1 RTI International Company Details
11.17.2 RTI International Business Overview
11.17.3 RTI International In Vivo and In Vitro ADME Introduction
11.17.4 RTI International Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.17.5 RTI International Recent Development
11.18 Eurofins Scientific
11.18.1 Eurofins Scientific Company Details
11.18.2 Eurofins Scientific Business Overview
11.18.3 Eurofins Scientific In Vivo and In Vitro ADME Introduction
11.18.4 Eurofins Scientific Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.18.5 Eurofins Scientific Recent Development
11.19 Aragen Life Sciences
11.19.1 Aragen Life Sciences Company Details
11.19.2 Aragen Life Sciences Business Overview
11.19.3 Aragen Life Sciences In Vivo and In Vitro ADME Introduction
11.19.4 Aragen Life Sciences Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.19.5 Aragen Life Sciences Recent Development
11.20 Sai Life Sciences
11.20.1 Sai Life Sciences Company Details
11.20.2 Sai Life Sciences Business Overview
11.20.3 Sai Life Sciences In Vivo and In Vitro ADME Introduction
11.20.4 Sai Life Sciences Revenue in In Vivo and In Vitro ADME Business (2020-2025)
11.20.5 Sai Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Charles River
LabCorp
ICON
Syneos Health
Envigo
Curia
Evotec AG
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences
List of Tables
 Table 1. Global In Vivo and In Vitro ADME Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Small Molecules
 Table 3. Key Players of Biologics
 Table 4. Global In Vivo and In Vitro ADME Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global In Vivo and In Vitro ADME Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global In Vivo and In Vitro ADME Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global In Vivo and In Vitro ADME Market Share by Region (2020-2025)
 Table 8. Global In Vivo and In Vitro ADME Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global In Vivo and In Vitro ADME Market Share by Region (2026-2031)
 Table 10. In Vivo and In Vitro ADME Market Trends
 Table 11. In Vivo and In Vitro ADME Market Drivers
 Table 12. In Vivo and In Vitro ADME Market Challenges
 Table 13. In Vivo and In Vitro ADME Market Restraints
 Table 14. Global In Vivo and In Vitro ADME Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global In Vivo and In Vitro ADME Market Share by Players (2020-2025)
 Table 16. Global Top In Vivo and In Vitro ADME Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo and In Vitro ADME as of 2024)
 Table 17. Ranking of Global Top In Vivo and In Vitro ADME Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by In Vivo and In Vitro ADME Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of In Vivo and In Vitro ADME, Headquarters and Area Served
 Table 20. Global Key Players of In Vivo and In Vitro ADME, Product and Application
 Table 21. Global Key Players of In Vivo and In Vitro ADME, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global In Vivo and In Vitro ADME Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global In Vivo and In Vitro ADME Revenue Market Share by Type (2020-2025)
 Table 25. Global In Vivo and In Vitro ADME Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global In Vivo and In Vitro ADME Revenue Market Share by Type (2026-2031)
 Table 27. Global In Vivo and In Vitro ADME Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global In Vivo and In Vitro ADME Revenue Market Share by Application (2020-2025)
 Table 29. Global In Vivo and In Vitro ADME Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global In Vivo and In Vitro ADME Revenue Market Share by Application (2026-2031)
 Table 31. North America In Vivo and In Vitro ADME Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America In Vivo and In Vitro ADME Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America In Vivo and In Vitro ADME Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe In Vivo and In Vitro ADME Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe In Vivo and In Vitro ADME Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe In Vivo and In Vitro ADME Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific In Vivo and In Vitro ADME Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific In Vivo and In Vitro ADME Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific In Vivo and In Vitro ADME Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America In Vivo and In Vitro ADME Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America In Vivo and In Vitro ADME Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America In Vivo and In Vitro ADME Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa In Vivo and In Vitro ADME Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa In Vivo and In Vitro ADME Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa In Vivo and In Vitro ADME Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Charles River Company Details
 Table 47. Charles River Business Overview
 Table 48. Charles River In Vivo and In Vitro ADME Product
 Table 49. Charles River Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 50. Charles River Recent Development
 Table 51. Labcorp Company Details
 Table 52. Labcorp Business Overview
 Table 53. Labcorp In Vivo and In Vitro ADME Product
 Table 54. Labcorp Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 55. Labcorp Recent Development
 Table 56. ICON Company Details
 Table 57. ICON Business Overview
 Table 58. ICON In Vivo and In Vitro ADME Product
 Table 59. ICON Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 60. ICON Recent Development
 Table 61. Syneos Health Company Details
 Table 62. Syneos Health Business Overview
 Table 63. Syneos Health In Vivo and In Vitro ADME Product
 Table 64. Syneos Health Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 65. Syneos Health Recent Development
 Table 66. Envigo Company Details
 Table 67. Envigo Business Overview
 Table 68. Envigo In Vivo and In Vitro ADME Product
 Table 69. Envigo Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 70. Envigo Recent Development
 Table 71. Curia Company Details
 Table 72. Curia Business Overview
 Table 73. Curia In Vivo and In Vitro ADME Product
 Table 74. Curia Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 75. Curia Recent Development
 Table 76. Evotec Company Details
 Table 77. Evotec Business Overview
 Table 78. Evotec In Vivo and In Vitro ADME Product
 Table 79. Evotec Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 80. Evotec Recent Development
 Table 81. Bioduro-Sundia Company Details
 Table 82. Bioduro-Sundia Business Overview
 Table 83. Bioduro-Sundia In Vivo and In Vitro ADME Product
 Table 84. Bioduro-Sundia Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 85. Bioduro-Sundia Recent Development
 Table 86. Lonza Company Details
 Table 87. Lonza Business Overview
 Table 88. Lonza In Vivo and In Vitro ADME Product
 Table 89. Lonza Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 90. Lonza Recent Development
 Table 91. WuXi AppTec Company Details
 Table 92. WuXi AppTec Business Overview
 Table 93. WuXi AppTec In Vivo and In Vitro ADME Product
 Table 94. WuXi AppTec Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 95. WuXi AppTec Recent Development
 Table 96. IQVIA Company Details
 Table 97. IQVIA Business Overview
 Table 98. IQVIA In Vivo and In Vitro ADME Product
 Table 99. IQVIA Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 100. IQVIA Recent Development
 Table 101. Tecan Group Company Details
 Table 102. Tecan Group Business Overview
 Table 103. Tecan Group In Vivo and In Vitro ADME Product
 Table 104. Tecan Group Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 105. Tecan Group Recent Development
 Table 106. Pharmaron Company Details
 Table 107. Pharmaron Business Overview
 Table 108. Pharmaron In Vivo and In Vitro ADME Product
 Table 109. Pharmaron Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 110. Pharmaron Recent Development
 Table 111. Shanghai Medicilon Company Details
 Table 112. Shanghai Medicilon Business Overview
 Table 113. Shanghai Medicilon In Vivo and In Vitro ADME Product
 Table 114. Shanghai Medicilon Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 115. Shanghai Medicilon Recent Development
 Table 116. ChemPartner Company Details
 Table 117. ChemPartner Business Overview
 Table 118. ChemPartner In Vivo and In Vitro ADME Product
 Table 119. ChemPartner Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 120. ChemPartner Recent Development
 Table 121. Joinn Laboratories Company Details
 Table 122. Joinn Laboratories Business Overview
 Table 123. Joinn Laboratories In Vivo and In Vitro ADME Product
 Table 124. Joinn Laboratories Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 125. Joinn Laboratories Recent Development
 Table 126. RTI International Company Details
 Table 127. RTI International Business Overview
 Table 128. RTI International In Vivo and In Vitro ADME Product
 Table 129. RTI International Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 130. RTI International Recent Development
 Table 131. Eurofins Scientific Company Details
 Table 132. Eurofins Scientific Business Overview
 Table 133. Eurofins Scientific In Vivo and In Vitro ADME Product
 Table 134. Eurofins Scientific Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 135. Eurofins Scientific Recent Development
 Table 136. Aragen Life Sciences Company Details
 Table 137. Aragen Life Sciences Business Overview
 Table 138. Aragen Life Sciences In Vivo and In Vitro ADME Product
 Table 139. Aragen Life Sciences Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 140. Aragen Life Sciences Recent Development
 Table 141. Sai Life Sciences Company Details
 Table 142. Sai Life Sciences Business Overview
 Table 143. Sai Life Sciences In Vivo and In Vitro ADME Product
 Table 144. Sai Life Sciences Revenue in In Vivo and In Vitro ADME Business (2020-2025) & (US$ Million)
 Table 145. Sai Life Sciences Recent Development
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources
 Table 149. Authors List of This Report


List of Figures
 Figure 1. In Vivo and In Vitro ADME Picture
 Figure 2. Global In Vivo and In Vitro ADME Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global In Vivo and In Vitro ADME Market Share by Type: 2024 VS 2031
 Figure 4. Small Molecules Features
 Figure 5. Biologics Features
 Figure 6. Global In Vivo and In Vitro ADME Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global In Vivo and In Vitro ADME Market Share by Application: 2024 VS 2031
 Figure 8. Biopharmaceutical Companies Case Studies
 Figure 9. Government and Academic Institutes Case Studies
 Figure 10. Others Case Studies
 Figure 11. In Vivo and In Vitro ADME Report Years Considered
 Figure 12. Global In Vivo and In Vitro ADME Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global In Vivo and In Vitro ADME Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global In Vivo and In Vitro ADME Market Share by Region: 2024 VS 2031
 Figure 15. Global In Vivo and In Vitro ADME Market Share by Players in 2024
 Figure 16. Global Top In Vivo and In Vitro ADME Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo and In Vitro ADME as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by In Vivo and In Vitro ADME Revenue in 2024
 Figure 18. North America In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America In Vivo and In Vitro ADME Market Share by Country (2020-2031)
 Figure 20. United States In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe In Vivo and In Vitro ADME Market Share by Country (2020-2031)
 Figure 24. Germany In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific In Vivo and In Vitro ADME Market Share by Region (2020-2031)
 Figure 32. China In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America In Vivo and In Vitro ADME Market Share by Country (2020-2031)
 Figure 40. Mexico In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa In Vivo and In Vitro ADME Market Share by Country (2020-2031)
 Figure 44. Turkey In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE In Vivo and In Vitro ADME Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Charles River Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 48. Labcorp Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 49. ICON Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 50. Syneos Health Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 51. Envigo Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 52. Curia Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 53. Evotec Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 54. Bioduro-Sundia Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 55. Lonza Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 56. WuXi AppTec Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 57. IQVIA Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 58. Tecan Group Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 59. Pharmaron Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 60. Shanghai Medicilon Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 61. ChemPartner Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 62. Joinn Laboratories Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 63. RTI International Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 64. Eurofins Scientific Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 65. Aragen Life Sciences Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 66. Sai Life Sciences Revenue Growth Rate in In Vivo and In Vitro ADME Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

In Vitro ADME Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vitro ADME Services Market
In Vivo and In Vitro ADME and PK Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vitro ADME Tox Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vivo and In Vitro DMPK and ADME Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global In Vivo Pharmacology Service Market Research Report 2024
Global In Vivo Pharmacology Market Research Report 2025
Global In Vitro ADME Testing Services Market Insights Forecast to 2030
Global In Vivo Pharmacology Model Market Research Report 2024
Global In Vitro Drug Release Testing Market Research Report 2024
Global Drug Metabolism and Pharmacokinetics DMPK Service Market Research Report 2024
Global Radiolabelled ADME Studies Market Research Report 2024
Global In Vitro Assay Development Service Market Research Report 2024
In Vitro Toxicity Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global In Vitro Release Test Studies Market Research Report 2025
Global In Vitro Dermal Permeation Test Market Research Report 2024
Global Preclinical In vivo Imaging Market Research Report 2024
Global In Vitro Skin Model Market Research Report 2024
Global In Vitro Lung Model Market Research Report 2024
Global In Vitro Safety Pharmacology Profiling Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions